Figure 4.

The cumulative local recurrence-free survival (LRFS) of patients with high sN-CAD levels, compared to patients with low sN-CAD levels.

Niimi et al. BMC Cancer 2013 13:309   doi:10.1186/1471-2407-13-309
Download authors' original image